SOX2 and breast cancer: We chose the MCF7 breast cancer cells as a model cell line to study the temporal dynamics of the incorporation of DNAme, as these cells express high levels of SOX2, and the promoter does not contain methylated CpG dinucleotides (Figure 2a).